Bank of New York Mellon’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Sell |
118,975
-1,458
| -1% | -$12.8K | ﹤0.01% | 3092 |
|
|
2025
Q1 | $902K | Buy |
120,433
+11,946
| +11% | +$89.5K | ﹤0.01% | 3114 |
|
|
2024
Q4 | $905K | Sell |
108,487
-37,365
| -26% | -$312K | ﹤0.01% | 3198 |
|
|
2024
Q3 | $1.01M | Sell |
145,852
-74,647
| -34% | -$518K | ﹤0.01% | 3129 |
|
|
2024
Q2 | $1.08M | Buy |
220,499
+21,231
| +11% | +$104K | ﹤0.01% | 3150 |
|
|
2024
Q1 | $1.16M | Sell |
199,268
-3,505
| -2% | -$20.3K | ﹤0.01% | 3067 |
|
|
2023
Q4 | $1.33M | Hold |
202,773
| – | – | ﹤0.01% | 3040 |
|
|
2023
Q3 | $977K | Sell |
202,773
-110
| -0.1% | -$530 | ﹤0.01% | 3159 |
|
|
2023
Q2 | $1.03M | Buy |
202,883
+88,257
| +77% | +$450K | ﹤0.01% | 3175 |
|
|
2023
Q1 | $630K | Hold |
114,626
| – | – | ﹤0.01% | 3368 |
|
|
2022
Q4 | $526K | Sell |
114,626
-3,540
| -3% | -$16.2K | ﹤0.01% | 3515 |
|
|
2022
Q3 | $738K | Hold |
118,166
| – | – | ﹤0.01% | 3356 |
|
|
2022
Q2 | $527K | Sell |
118,166
-45,451
| -28% | -$203K | ﹤0.01% | 3548 |
|
|
2022
Q1 | $823K | Buy |
163,617
+76,273
| +87% | +$384K | ﹤0.01% | 3426 |
|
|
2021
Q4 | $761K | Buy |
87,344
+1,890
| +2% | +$16.5K | ﹤0.01% | 3546 |
|
|
2021
Q3 | $797K | Buy |
85,454
+12,809
| +18% | +$119K | ﹤0.01% | 3531 |
|
|
2021
Q2 | $931K | Buy |
+72,645
| New | +$931K | ﹤0.01% | 3461 |
|
|
2019
Q1 | – | Sell |
-1,280
| Closed | -$36K | – | 4250 |
|
|
2018
Q4 | $36K | Buy |
1,280
+193
| +18% | +$5.43K | ﹤0.01% | 4095 |
|
|
2018
Q3 | $84K | Sell |
1,087
-44
| -4% | -$3.4K | ﹤0.01% | 4050 |
|
|
2018
Q2 | $118K | Sell |
1,131
-263
| -19% | -$27.4K | ﹤0.01% | 3976 |
|
|
2018
Q1 | $176K | Buy |
1,394
+122
| +10% | +$15.4K | ﹤0.01% | 3948 |
|
|
2017
Q4 | $82K | Buy |
1,272
+68
| +6% | +$4.38K | ﹤0.01% | 4116 |
|
|
2017
Q3 | $71K | Hold |
1,204
| – | – | ﹤0.01% | 4048 |
|
|
2017
Q2 | $77K | Sell |
1,204
-224
| -16% | -$14.3K | ﹤0.01% | 4070 |
|
|
2017
Q1 | $112K | Buy |
1,428
+213
| +18% | +$16.7K | ﹤0.01% | 3999 |
|
|
2016
Q4 | $57K | Buy |
+1,215
| New | +$57K | ﹤0.01% | 4113 |
|